Diana Handke Selected Research

Member 2 Subfamily B ATP Binding Cassette Transporter

8/2020	Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
1/2020	Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Handke Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 06/2006
6	Melanoma (Melanoma, Malignant) 01/2022 - 01/2011
4	Carcinoma (Carcinomatosis) 04/2024 - 06/2006
2	Disease Progression 01/2022 - 04/2010
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 04/2024
1	Infertility (Sterility) 04/2024
1	Insulin Resistance 04/2024
1	Obesity 04/2024
1	Oligospermia (Oligozoospermia) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2011
1	Prostatic Neoplasms (Prostate Cancer) 04/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2009
1	Ovarian Neoplasms (Ovarian Cancer) 06/2006

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 04/2024 - 11/2019
4	Histocompatibility Antigens Class IIBA 08/2020 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2010
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
3	Surface Antigens (Surface Antigen)IBA 08/2020 - 06/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2021 - 01/2020
2	Member 2 Subfamily B ATP Binding Cassette TransporterIBA 08/2020 - 01/2020
2	tapasinIBA 01/2020 - 10/2010
2	transporter associated with antigen processing (TAP)IBA 01/2020 - 10/2010
2	AntigensIBA 10/2019 - 01/2011
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2011 - 06/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Testosterone (Sustanon)FDA Link 04/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	LigandsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Histocompatibility Antigens Class IIIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2020
1	Horseradish PeroxidaseIBA 01/2020
1	InterferonsIBA 01/2020
1	LuciferasesIBA 01/2020
1	ParaffinIBA 01/2020
1	Bovine Serum AlbuminIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Firefly LuciferasesIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 11/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2019
1	AntibodiesIBA 10/2019
1	HLA-B Antigens (HLA-B)IBA 10/2011
1	HLA-A Antigens (HLA-A)IBA 10/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2011
1	HydrolasesIBA 10/2009
1	hydrogen sulfite (bisulfite)IBA 10/2009
1	UbiquitinIBA 10/2009
1	DNA (Deoxyribonucleic Acid)IBA 10/2009

Therapy/Procedure

3	Therapeutics 11/2019 - 01/2011
3	Immunotherapy 10/2019 - 04/2010
1	Ligation 10/2011